IBOV 177,512.41 ▼ 0.27% IPSA 11,014.88 ▼ 0.02% IPC MEX 66,935.53 ▼ 0.58% MERVAL 3,287,637 ▼ 0.11% COLCAP 2,382.69 ▼ 0.39% BVL PERÚ 57,378.30 — — USD/BRL5.09▲ 0.27% USD/MXN17.32▲ 0.07% USD/CLP924.27▼ 0.73% USD/COP3,229▲ 0.83% USD/PEN3.39▲ 0.07% USD/ARS1,494▲ 0.57% USD/UYU40.27▲ 0.17% USD/PYG5,936▲ 0.08% USD/BOB12.07▼ 0.25% USD/DOP58.00▲ 0.02% USD/CRC448.42— 0.00% USD/GTQ7.62▼ 0.08% USD/HNL26.78▲ 0.07% USD/NIO 36.62 — 0.00% USD/VES746.91▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD156.98▼ 0.13% USD/TTD6.74▲ 0.40% EUR/BRL5.86▼ 0.05% BRENT 83.78 ▼ 7.04% WTI 80.32 ▼ 5.14% IRON ORE 161.91 — — COPPER 6.54 ▲ 1.58% GOLD 4,093 ▲ 1.09% SILVER 58.06 ▲ 0.81% SOY 1,192 ▲ 1.73% CORN 473.00 ▲ 7.32% WHEAT 651.50 ▲ 1.92% COFFEE 321.15 ▼ 3.30% SUGAR 15.01 ▲ 2.39% ORANGE JUICE 159.20 ▲ 2.74% COTTON 81.39 ▲ 1.11% COCOA 5,903 ▲ 9.38% BEEF 227.03 ▼ 2.04% CATTLE 343.00 ▼ 1.44% LITHIUM 69.24 ▲ 0.03% PETR4 42.87 ▼ 1.27% VALE3 74.43 ▼ 2.43% ITUB4 42.98 ▲ 0.25% BBDC4 18.51 ▲ 0.54% ABEV3 15.78 ▼ 1.31% BBAS3 21.28 ▼ 0.33% B3SA3 15.60 ▼ 0.83% WEGE3 48.33 ▲ 2.39% PRIO3 58.91 ▼ 3.19% SUZB3 43.39 ▲ 0.16% RENT3 37.99 ▲ 1.01% AZZA3 16.09 ▼ 2.01% CSAN3 4.12 ▲ 1.23% RAIZ4 0.26 — 0.00% PCAR3 2.70 ▲ 4.25% GMAT3 3.98 ▼ 1.24% PSSA3 54.37 ▼ 0.60% CVCB3 1.42 ▲ 8.40% POSI3 3.52 ▼ 0.85% SLCE3 13.45 ▲ 0.52% NATU3 8.46 ▲ 0.95% BRKM5 5.89 ▼ 1.34% RANI3 8.43 ▲ 3.95% CSNA3 4.56 ▼ 5.79% CMIN3 5.69 ▼ 0.35% USIM5 7.57 ▲ 2.85% GGBR4 25.34 ▲ 1.44% ENEV3 26.70 ▲ 1.48% CPFE3 45.84 ▼ 0.65% CMIG4 11.15 ▼ 1.68% EQTL3 38.73 ▲ 0.18% LREN3 13.80 ▲ 1.47% VIVT3 32.39 ▼ 0.74% RAIL3 14.16 ▼ 1.94% KLABIN 18.27 ▲ 0.11% RAIA DROGASIL 18.51 ▲ 0.16% RDOR3 34.04 ▼ 1.73% HAPV3 11.87 ▲ 5.23% FLRY3 17.28 ▲ 0.82% SMTO3 14.33 ▼ 1.31% UGPA3 32.99 ▼ 0.18% VBBR3 36.20 ▲ 0.42% BBSE3 41.52 ▲ 0.63% BPAC11 57.18 ▲ 0.67% CURY3 31.37 ▲ 4.25% AERI3 2.15 — 0.00% VIVARA 22.73 ▲ 2.48% COMPASS 24.86 ▲ 0.08% VAMOS 3.28 ▼ 1.80% SANB11 28.84 ▲ 0.77% ASAI3 8.46 ▼ 0.47% SBSP3 27.28 ▼ 1.52% WALMEX 49.79 ▼ 0.92% GMEXICO 212.72 ▲ 2.41% FEMSA 217.50 ▼ 1.78% CEMEX 20.61 ▲ 0.49% GFNORTE 198.39 ▼ 1.09% BIMBO 61.35 ▼ 0.98% TELEVISA 9.69 ▼ 1.22% AMX 21.60 ▼ 2.13% GAP 377.00 ▲ 0.12% ASUR 277.22 ▲ 0.58% OMA 230.70 ▼ 0.27% KOF 185.65 ▼ 0.86% GRUMA 263.49 ▲ 2.04% KIMBER 40.15 ▼ 0.12% SQM-B 61,800 ▼ 1.44% COPEC 6,287 ▼ 0.99% BSANTANDER 80.10 ▼ 1.10% FALABELLA 6,320 ▲ 1.67% ENELAM 87.54 ▼ 0.51% CENCOSUD 1,949 ▼ 0.30% CMPC 1,068 ▲ 1.20% BANCO CHILE 191.73 ▼ 1.02% LATAM AIR 25.22 ▲ 1.94% YPF 8,130 ▼ 1.93% GGAL 8,000 ▲ 1.50% PAMPA 5,515 ▼ 0.72% TXAR 655.00 ▼ 0.68% ALUAR 968.00 ▼ 0.97% TGS 9,930 ▼ 1.19% CEPU 2,387 ▼ 0.38% MIRGOR 1,655 ▼ 89.88% COME 43.28 ▼ 1.70% LOMA NEGRA 3,565 ▼ 1.52% BYMA 293.25 ▼ 0.76% TELECOM ARG 4,385 ▼ 0.51% ECOPETROL 16.59 ▼ 1.10% BANCOLOMBIA 91.08 ▼ 1.56% GRUPO AVAL 5.25 ▼ 0.57% CREDICORP 396.97 ▼ 0.90% SOUTHERN COPPER 186.12 ▲ 1.87% BUENAVENTURA 30.28 — 0.00% MERCADOLIBRE 1,892 ▲ 0.73% NUBANK 14.51 ▲ 1.22% XP 17.07 ▲ 0.03% PAGSEGURO 9.68 ▲ 0.36% STONE 11.31 ▼ 0.62% GLOBANT 37.44 ▲ 2.30% TECNOGLASS 46.21 ▲ 6.38% GAP AIRPORT 217.37 ▲ 0.01% ASUR 277.22 ▲ 0.58% OMA AIRPORT 106.57 ▼ 0.31% AMX ADR 24.86 ▼ 1.93% FEMSA ADR 125.49 ▼ 1.96% CEMEX ADR 11.87 ▲ 0.38% PETROBRAS ADR 19.05 ▼ 1.83% VALE ADR 14.57 ▼ 3.25% ITAU ADR 8.45 ▼ 0.12% SANTANDER BR 5.70 ▲ 0.53% AMBEV ADR 3.06 ▼ 1.61% CSN 0.91 ▼ 7.38% GERDAU 5.00 ▲ 0.71% LATAM ADR 54.52 ▲ 3.33% BTC 63,761 ▲ 0.44% ETH 1,867 ▼ 0.81% SOL 73.98 ▲ 0.72% XRP 1.08 ▼ 0.35% BNB 590.88 ▲ 0.56% ADA 0.19 ▲ 2.51% DOGE 0.07 ▼ 0.45% AVAX 6.54 ▼ 0.02% LINK 8.23 ▼ 1.69% DOT 0.83 ▲ 3.92% LTC 44.16 ▼ 1.06% BCH 213.71 ▲ 0.56% TRX 0.33 ▲ 0.71% XLM 0.17 ▼ 1.43% HBAR 0.07 ▲ 0.80% NEAR 1.74 ▲ 1.66% ATOM 1.34 ▲ 6.34% AAVE 92.98 ▲ 1.06% SELIC 14.25% EMBRAER 90.60 ▲ 4.27% EMBRAER ADR 71.23 ▲ 4.24% JBS 13.81 ▼ 1.50% JBS BDR 70.23 ▼ 0.66% MBRF3 17.76 ▲ 1.25% MBRFY 3.42 ▼ 0.58% INTER 5.63 ▲ 0.45% EGX 54,094 ▼ 0.35% USD/ZAR16.53▼ 0.14% USD/NGN1,361▲ 0.07% NIKKEI 63,755 ▼ 0.94% CSI300 4,543 ▼ 0.98% HSI 26,009 ▲ 0.48% NIFTY 24,774 ▲ 1.60% KOSPI 6,257 ▼ 5.12% JCI 6,234 ▼ 0.03% USD/JPY156.82▼ 0.40% USD/CNY6.74▼ 0.12% DAX 26,001 ▲ 1.45% CAC 8,614 ▲ 1.22% FTSE 10,858 ▼ 0.10% MIB 52,872 ▲ 1.34% IBEX 19,983 ▲ 1.01% STOXX 652.09 ▲ 0.45% EUR/USD1.15▼ 0.25% GBP/USD1.34▼ 0.42% SPX 7,604 ▲ 1.53% DJI 53,145 ▲ 1.26% NDX 28,787 ▲ 1.81% RUT 2,980 ▲ 1.65% TSX 35,226 ▼ 0.79% VIX 15.77 ▼ 1.38% USD/CAD1.40▲ 0.25% US10Y 4.6880 ▼ 1.20% IBOV 177,512.41 ▼ 0.27% IPSA 11,014.88 ▼ 0.02% IPC MEX 66,935.53 ▼ 0.58% MERVAL 3,287,637 ▼ 0.11% COLCAP 2,382.69 ▼ 0.39% BVL PERÚ 57,378.30 — — USD/BRL 5.09 ▲ 0.27% USD/MXN 17.32 ▲ 0.07% USD/CLP 924.27 ▼ 0.73% USD/COP 3,229 ▲ 0.83% USD/PEN 3.39 ▲ 0.07% USD/ARS 1,494 ▲ 0.57% USD/UYU 40.27 ▲ 0.17% USD/PYG 5,936 ▲ 0.08% USD/BOB 12.07 ▼ 0.25% USD/DOP 58.00 ▲ 0.02% USD/CRC 448.42 ▲ 0.00% USD/GTQ 7.62 ▼ 0.08% USD/HNL 26.78 ▲ 0.07% USD/NIO 36.62 — 0.00% USD/VES 746.91 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 156.98 ▲ 0.24% USD/TTD 6.74 ▲ 1.26% EUR/BRL 5.86 ▼ 0.05% BRENT 83.78 ▼ 7.04% WTI 80.32 ▼ 5.14% IRON ORE 161.91 — — COPPER 6.54 ▲ 1.58% GOLD 4,093 ▲ 1.09% SILVER 58.06 ▲ 0.81% SOY 1,192 ▲ 1.73% CORN 473.00 ▲ 7.32% WHEAT 651.50 ▲ 1.92% COFFEE 321.15 ▼ 3.30% SUGAR 15.01 ▲ 2.39% ORANGE JUICE 159.20 ▲ 2.74% COTTON 81.39 ▲ 1.11% COCOA 5,903 ▲ 9.38% BEEF 227.03 ▼ 2.04% CATTLE 343.00 ▼ 1.44% LITHIUM 69.24 ▲ 0.03% PETR4 42.87 ▼ 1.27% VALE3 74.43 ▼ 2.43% ITUB4 42.98 ▲ 0.25% BBDC4 18.51 ▲ 0.54% ABEV3 15.78 ▼ 1.31% BBAS3 21.28 ▼ 0.33% B3SA3 15.60 ▼ 0.83% WEGE3 48.33 ▲ 2.39% PRIO3 58.91 ▼ 3.19% SUZB3 43.39 ▲ 0.16% RENT3 37.99 ▲ 1.01% AZZA3 16.09 ▼ 2.01% CSAN3 4.12 ▲ 1.23% RAIZ4 0.26 — 0.00% PCAR3 2.70 ▲ 4.25% GMAT3 3.98 ▼ 1.24% PSSA3 54.37 ▼ 0.60% CVCB3 1.42 ▲ 8.40% POSI3 3.52 ▼ 0.85% SLCE3 13.45 ▲ 0.52% NATU3 8.46 ▲ 0.95% BRKM5 5.89 ▼ 1.34% RANI3 8.43 ▲ 3.95% CSNA3 4.56 ▼ 5.79% CMIN3 5.69 ▼ 0.35% USIM5 7.57 ▲ 2.85% GGBR4 25.34 ▲ 1.44% ENEV3 26.70 ▲ 1.48% CPFE3 45.84 ▼ 0.65% CMIG4 11.15 ▼ 1.68% EQTL3 38.73 ▲ 0.18% LREN3 13.80 ▲ 1.47% VIVT3 32.39 ▼ 0.74% RAIL3 14.16 ▼ 1.94% KLABIN 18.27 ▲ 0.11% RAIA DROGASIL 18.51 ▲ 0.16% RDOR3 34.04 ▼ 1.73% HAPV3 11.87 ▲ 5.23% FLRY3 17.28 ▲ 0.82% SMTO3 14.33 ▼ 1.31% UGPA3 32.99 ▼ 0.18% VBBR3 36.20 ▲ 0.42% BBSE3 41.52 ▲ 0.63% BPAC11 57.18 ▲ 0.67% CURY3 31.37 ▲ 4.25% AERI3 2.15 — 0.00% VIVARA 22.73 ▲ 2.48% COMPASS 24.86 ▲ 0.08% VAMOS 3.28 ▼ 1.80% SANB11 28.84 ▲ 0.77% ASAI3 8.46 ▼ 0.47% SBSP3 27.28 ▼ 1.52% WALMEX 49.79 ▼ 0.92% GMEXICO 212.72 ▲ 2.41% FEMSA 217.50 ▼ 1.78% CEMEX 20.61 ▲ 0.49% GFNORTE 198.39 ▼ 1.09% BIMBO 61.35 ▼ 0.98% TELEVISA 9.69 ▼ 1.22% AMX 21.60 ▼ 2.13% GAP 377.00 ▲ 0.12% ASUR 277.22 ▲ 0.58% OMA 230.70 ▼ 0.27% KOF 185.65 ▼ 0.86% GRUMA 263.49 ▲ 2.04% KIMBER 40.15 ▼ 0.12% SQM-B 61,800 ▼ 1.44% COPEC 6,287 ▼ 0.99% BSANTANDER 80.10 ▼ 1.10% FALABELLA 6,320 ▲ 1.67% ENELAM 87.54 ▼ 0.51% CENCOSUD 1,949 ▼ 0.30% CMPC 1,068 ▲ 1.20% BANCO CHILE 191.73 ▼ 1.02% LATAM AIR 25.22 ▲ 1.94% YPF 8,130 ▼ 1.93% GGAL 8,000 ▲ 1.50% PAMPA 5,515 ▼ 0.72% TXAR 655.00 ▼ 0.68% ALUAR 968.00 ▼ 0.97% TGS 9,930 ▼ 1.19% CEPU 2,387 ▼ 0.38% MIRGOR 1,655 ▼ 89.88% COME 43.28 ▼ 1.70% LOMA NEGRA 3,565 ▼ 1.52% BYMA 293.25 ▼ 0.76% TELECOM ARG 4,385 ▼ 0.51% ECOPETROL 16.59 ▼ 1.10% BANCOLOMBIA 91.08 ▼ 1.56% GRUPO AVAL 5.25 ▼ 0.57% CREDICORP 396.97 ▼ 0.90% SOUTHERN COPPER 186.12 ▲ 1.87% BUENAVENTURA 30.28 — 0.00% MERCADOLIBRE 1,892 ▲ 0.73% NUBANK 14.51 ▲ 1.22% XP 17.07 ▲ 0.03% PAGSEGURO 9.68 ▲ 0.36% STONE 11.31 ▼ 0.62% GLOBANT 37.44 ▲ 2.30% TECNOGLASS 46.21 ▲ 6.38% GAP AIRPORT 217.37 ▲ 0.01% ASUR 277.22 ▲ 0.58% OMA AIRPORT 106.57 ▼ 0.31% AMX ADR 24.86 ▼ 1.93% FEMSA ADR 125.49 ▼ 1.96% CEMEX ADR 11.87 ▲ 0.38% PETROBRAS ADR 19.05 ▼ 1.83% VALE ADR 14.57 ▼ 3.25% ITAU ADR 8.45 ▼ 0.12% SANTANDER BR 5.70 ▲ 0.53% AMBEV ADR 3.06 ▼ 1.61% CSN 0.91 ▼ 7.38% GERDAU 5.00 ▲ 0.71% LATAM ADR 54.52 ▲ 3.33% BTC 63,761 ▲ 0.44% ETH 1,867 ▼ 0.81% SOL 73.98 ▲ 0.72% XRP 1.08 ▼ 0.35% BNB 590.88 ▲ 0.56% ADA 0.19 ▲ 2.51% DOGE 0.07 ▼ 0.45% AVAX 6.54 ▼ 0.02% LINK 8.23 ▼ 1.69% DOT 0.83 ▲ 3.92% LTC 44.16 ▼ 1.06% BCH 213.71 ▲ 0.56% TRX 0.33 ▲ 0.71% XLM 0.17 ▼ 1.43% HBAR 0.07 ▲ 0.80% NEAR 1.74 ▲ 1.66% ATOM 1.34 ▲ 6.34% AAVE 92.98 ▲ 1.06% SELIC 14.25% EMBRAER 90.60 ▲ 4.27% EMBRAER ADR 71.23 ▲ 4.24% JBS 13.81 ▼ 1.50% JBS BDR 70.23 ▼ 0.66% MBRF3 17.76 ▲ 1.25% MBRFY 3.42 ▼ 0.58% INTER 5.63 ▲ 0.45% EGX 54,094 ▼ 0.35% USD/ZAR 16.53 ▼ 0.09% USD/NGN 1,361 ▼ 0.23% NIKKEI 63,755 ▼ 0.94% CSI300 4,543 ▼ 0.98% HSI 26,009 ▲ 0.48% NIFTY 24,774 ▲ 1.60% KOSPI 6,257 ▼ 5.12% JCI 6,234 ▼ 0.03% USD/JPY 156.87 ▼ 0.34% USD/CNY 6.7434 ▼ 0.02% DAX 26,001 ▲ 1.45% CAC 8,614 ▲ 1.22% FTSE 10,858 ▼ 0.10% MIB 52,872 ▲ 1.34% IBEX 19,983 ▲ 1.01% STOXX 652.09 ▲ 0.45% EUR/USD 1.1515 ▼ 0.10% GBP/USD 1.3429 ▼ 0.43% SPX 7,604 ▲ 1.53% DJI 53,145 ▲ 1.26% NDX 28,787 ▲ 1.81% RUT 2,980 ▲ 1.65% TSX 35,226 ▼ 0.79% VIX 15.77 ▼ 1.38% USD/CAD 1.4041 ▲ 0.17% US10Y 4.6880 ▼ 1.20%
since 2009
Monday, August 3, 2026

Brazil Covid-19

Covid-19 : Brazil doctors denounce Prevent Senior for promoting ineffective medications to patients

By · October 11, 2021 · 3 min read

Daily Brief

The morning intel from across Latin America. Free.

By subscribing you agree to our privacy policy. We never share your email.

RIO DE JANEIRO, BRAZIL – Irene Castilho was not even allowed a day to mourn after her husband died of Covid-19. She too was sick, coughing and struggling to breathe; he had barely passed away when she began using the same oxygen mask. That same day, March 22, she was admitted to a São Paulo hospital.

The 71-year-old had followed doctors’ instructions to the letter, dutifully taking her hydroxychloroquine doses. She also took ivermectin and a battery of anti-inflammatory drugs and vitamins from the so-called “Covid kit” that her health care company, Prevent Senior, mailed to her home.

Medical care in the Brazilian health care system is often deficient. (photo internet reproduction)
One-stop reference
Company Intelligence
Every listed company in Latin America — financials, ownership and structure for 1,450+ companies across 26 exchanges, in one place.
Browse the directory →
RT
Ask Rio Times
This story and the bigger picture.
Open the full Ask Rio Times →

Nevertheless, her health deteriorated.

In the hospital, Castilho was put on dialysis and intubated. When doctors consulted her daughters about administering flutamide, a drug typically used for prostate cancer, they declined, concerned about potential side effects for their mother, a liver cancer survivor.

They later saw a nurse administer flutamide to their mother; she told them it had been prescribed despite their objection.

Castilho died in late April, 33 days after her husband, and her daughters scattered her ashes on his grave.

Castilho’s case is one of several examples that have led to inflammatory accusations against Prevent Senior, which operates 10 hospitals in São Paulo, and have scandalized Brazil since mid-September.

Whistleblower doctors, through their attorney, testified in the Senate last week that Prevent Senior recruited participants to supply untested drugs without appropriate consent and forced doctors to prescribe untested drugs touted by President Jair Bolsonaro as part of the “Covid kit.”

Several senators have said it appears that Prevent Senior falsified death certificates to omit Covid-19 as the cause of death. Authorities are also investigating complaints that the company conducted the research without the appropriate authorization.

The case underscores the sharp divide in Brazil over the adequate treatment of Covid-19 patients, with many in the nation, including the President – who is not vaccinated – opposing global scientific recommendations. And there is concern that other providers have also implemented unreliable policies.

Two weeks ago, Prevent Senior’s CEO Pedro Batista Júnior told senators that doctors have the right to treat Covid-19 patients as they see fit, and that patients had freely agreed to take the Covid kits.

Replying to questions sent by The Associated Press, Prevent Senior denied any wrongdoing, stating that all patients and their relatives used its products after providing full consent.

Medical care in the Brazilian health care system is often deficient. Many middle-class patients have private health insurance, but costs can be high, particularly for the elderly.

Prevent Senior seemed to be a solution. It was founded in 1997 and became popular among people who could not afford exclusive medical services. It costs approximately US$300 per month, half what its competitors charge. It has over 500,000 customers, whose average age is 68.

Hydroxychloroquine has been promoted by President Bolsonaro and those close to him. While some studies early in the pandemic considered it promising, these same studies that never made it out of the lab. Since then, more extensive research has shown it to be not only ineffective against Covid-19 but also potentially harmful.

The doctors also say they were advised to use ivermectin, an anti-parasitic drug that has not been proven effective against Covid-19. The American Medical Association advises against its use outside laboratories.

Pressure to prescribe hydroxychloroquine and ivermectin is evident in internal Prevent Senior messages collected by The Associated Press and previously submitted to the Senate Committee investigating the Brazilian government’s response to the coronavirus pandemic.

Among these messages are those from Benedito Júnior, another executive, 2 clinic directors and an unidentified doctor.

Bruna Morato, an attorney representing 12 doctors employed by Prevent Senior, testified before the Senate Committee on September 12 that the doctors were told that they would lose their jobs should they not prescribe the drugs.

Source: Infobae

This article was produced by The Rio Times’ automated newsroom system. How we use AI · Report an error

Read More from The Rio Times

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.